Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
News Medical

Manufacturing processes for active pharmaceutical ingredients (APIs)

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
Contract Pharma

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
Business Wire

Regis Expands Facilities to Support Rising Demand for U.S.-Based Custom API Pharmaceutical Development and Manufacturing

−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...
News Medical

The Power of Process Analytical Technology (PAT) in Pharmaceutical Manufacturing

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Small Molecule API Market Size to Reach USD 328.03 Billion by 2033, Driven by Rising Demand for Cost-Effective Therapeutics – SNS Insider

Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
ksn.com

INTERNATIONAL PROCESS PLANTS ANNOUNCES PURCHASE OF WORLD-CLASS GRIMSBY, UK API PHARMACEUTICAL MANUFACTURING SITE FROM NOVARTIS

"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...
PharmTech

Advancing Pharmaceutical Quality through Integrated Digital Systems and Collaborative Scientific Innovation

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...

High Purity Acetic Acid Market to Reach $136.5M by 2033 – Strategic Revenue Insights (SRI)

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
FiercePharma

Contract Manufacturing in Pharmaceutical Industry, 2015-2025 - North America and Europe are the predominant regions where majority of the production facilities of CMOs are located

The "Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025" report provides an extensive study of the rapidly growing pharmaceutical contract manufacturing market. With pharmaceutical and ...
PharmiWeb

Curia Invests $4 Million to Enhance Sterile API Manufacturing

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million ...
Mena FN

United States Active Pharmaceutical Ingredients (Apis) Market Research Report 2025-2033: Growth Driven By Generic Drug Growth, Biotech API Innovation, And Rising Investments In ...

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by 2033, growing at a 6.46% CAGR. This ...